TCA
AMED

Taconic Capital Advisors’s Amedisys AMED Stock Holding History

Taconic Capital Advisors’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-404,170
Closed -$38.2M – 73
2025
Q1 		$37.4M Buy
404,170
+160,049
+66% +$14.8M 2.65% 11
2024
Q4 		$22.2M Buy
244,121
+219,121
+876% +$20.1M 1.52% 15
2024
Q3 		$2.41M Sell
25,000
-30,191
-55% -$2.95M 0.2% 25
2024
Q2 		$5.07M Buy
+55,191
New +$5.12M 0.39% 28
2023
Q3 		– Sell
-175,000
Closed -$16M – 178
2023
Q2 		$16M Buy
+175,000
New +$14.4M 0.54% 29

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return

Taconic Capital Advisors's AMED Position: Q2 2025 in Review

Taconic Capital Advisors sold out of Amedisys (AMED) in Q2 2025, closing a stake of 404,170 shares — an estimated $38.2M sold.

Taconic Capital Advisors first reported a position in AMED in Q2 2023 and held it in 5 quarters. The position peaked at $37.4M in Q1 2025. 320 funds tracked by Wall St. Rank hold AMED as of Q2 2025.

  • Taconic Capital Advisors reported no remaining Amedisys position as of Q2 2025 after selling out during the quarter.
  • Taconic Capital Advisors sold 404,170 Amedisys shares in Q2 2025, an estimated $38.2M.
  • Taconic Capital Advisors first reported a position in Amedisys in Q2 2023 and held it in 5 quarters.
  • Taconic Capital Advisors's Amedisys position peaked at $37.4M in Q1 2025.
  • 320 funds tracked by Wall St. Rank held Amedisys as of Q2 2025.

Based on Taconic Capital Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.